DMK Pharmaceuticals Corporation
DMKPQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 115.3% | -20.5% | -87.4% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -60.9% | -211.1% | -127.9% | 29.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -495.7% | -1,387% | -1,206.7% | -113.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -556.7% | -2,074.9% | -1,778.8% | -124.4% |
| EPS Diluted | -12.37 | -22.25 | -44.57 | -36.16 |
| % Growth | 44.4% | 50.1% | -23.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |